176 related articles for article (PubMed ID: 22252975)
1. The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction.
Kim BM; Lee DH; Choi HJ; Lee KH; Kang SJ; Joe YA; Hong YK; Hong SH
IUBMB Life; 2012 Mar; 64(3):259-65. PubMed ID: 22252975
[TBL] [Abstract][Full Text] [Related]
2. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
[TBL] [Abstract][Full Text] [Related]
3. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways.
Chen ML; Lin YH; Yang CM; Hu ML
Mol Nutr Food Res; 2012 Jun; 56(6):889-99. PubMed ID: 22707264
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
[TBL] [Abstract][Full Text] [Related]
6. Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways.
Law AY; Wong CK
Mol Cell Endocrinol; 2013 Jul; 374(1-2):73-81. PubMed ID: 23664860
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
8. The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ.
Park JH; Lee KS; Lim HJ; Kim H; Kwak HJ; Park HY
J Cell Biochem; 2012 Jun; 113(6):1947-54. PubMed ID: 22234939
[TBL] [Abstract][Full Text] [Related]
9. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
[TBL] [Abstract][Full Text] [Related]
10. A biphasic endothelial stress-survival mechanism regulates the cellular response to vascular endothelial growth factor A.
Latham AM; Odell AF; Mughal NA; Issitt T; Ulyatt C; Walker JH; Homer-Vanniasinkam S; Ponnambalam S
Exp Cell Res; 2012 Nov; 318(18):2297-311. PubMed ID: 22796052
[TBL] [Abstract][Full Text] [Related]
11. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
13. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
[TBL] [Abstract][Full Text] [Related]
15. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
[TBL] [Abstract][Full Text] [Related]
16. Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo.
Saraswati S; Agrawal SS
Cancer Lett; 2013 May; 332(1):83-93. PubMed ID: 23348691
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
18. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
[TBL] [Abstract][Full Text] [Related]
19. Taspine downregulates VEGF expression and inhibits proliferation of vascular endothelial cells through PI3 kinase and MAP kinase signaling pathways.
Zhao J; Zhao L; Chen W; He L; Li X
Biomed Pharmacother; 2008; 62(6):383-9. PubMed ID: 17826025
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effect of tetraacetyl-phytosphingosine.
Kwon YB; Kim CD; Kim BJ; Kim MY; Park CS; Yoon TJ; Seo YJ; Suhr KB; Park JK; Lee JH
Exp Dermatol; 2007 Apr; 16(4):311-7. PubMed ID: 17359337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
